NO20015247D0 - Glysinspaltingssysteminhibitorer som potensielle antipsykotika - Google Patents

Glysinspaltingssysteminhibitorer som potensielle antipsykotika

Info

Publication number
NO20015247D0
NO20015247D0 NO20015247A NO20015247A NO20015247D0 NO 20015247 D0 NO20015247 D0 NO 20015247D0 NO 20015247 A NO20015247 A NO 20015247A NO 20015247 A NO20015247 A NO 20015247A NO 20015247 D0 NO20015247 D0 NO 20015247D0
Authority
NO
Norway
Prior art keywords
glycemic
system inhibitors
antipsychotics
potential
potential antipsychotics
Prior art date
Application number
NO20015247A
Other languages
English (en)
Other versions
NO20015247L (no
Inventor
Michael Arlt
Gerd Bartoszyk
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20015247D0 publication Critical patent/NO20015247D0/no
Publication of NO20015247L publication Critical patent/NO20015247L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO20015247A 1999-04-29 2001-10-26 Glysinspaltingssysteminhibitorer som potensielle antipsykotika NO20015247L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13164799P 1999-04-29 1999-04-29
EP99108480 1999-04-30
PCT/EP2000/003456 WO2000066110A1 (en) 1999-04-29 2000-04-17 Glycine cleavage system inhibitors as potential antipsychotics

Publications (2)

Publication Number Publication Date
NO20015247D0 true NO20015247D0 (no) 2001-10-26
NO20015247L NO20015247L (no) 2001-10-26

Family

ID=56290006

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015247A NO20015247L (no) 1999-04-29 2001-10-26 Glysinspaltingssysteminhibitorer som potensielle antipsykotika

Country Status (12)

Country Link
US (1) US6395780B1 (no)
EP (1) EP1185259A1 (no)
JP (1) JP2002543124A (no)
KR (1) KR20020008167A (no)
AU (1) AU4748100A (no)
BR (1) BR0010151A (no)
CA (1) CA2372073A1 (no)
CZ (1) CZ20013786A3 (no)
MX (1) MXPA01010933A (no)
NO (1) NO20015247L (no)
PL (1) PL353180A1 (no)
WO (1) WO2000066110A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1565185A4 (en) * 2002-11-07 2011-01-05 Technion Res & Dev Foundation NEUROPROTECTIVE IRON CHELATORS AND PHARMACEUTICAL COMPOSITIONS THEREWITH
GB2398497A (en) * 2003-02-19 2004-08-25 Walcom Animal Science Composition for improving immunity of animals
WO2004093910A1 (ja) * 2003-04-22 2004-11-04 Astellas Pharma Inc. ＰＰＡＲδアゴニストによる脳神経変性疾患治療剤
WO2005039548A2 (en) * 2003-10-15 2005-05-06 Probiodrug Ag Use of effectors of glutaminyl and glutamate cyclases
EP1686973A4 (en) 2003-11-25 2009-03-25 Technion Res & Dev Foundation COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND DISEASES
US8097608B2 (en) * 2003-11-25 2012-01-17 Technion Research And Development Foundation Ltd. Methods for treatment of cardiovascular disorders and diseases
JP2007517049A (ja) * 2003-12-29 2007-06-28 マクデビット、ジェイソン 再発性病状を治療するための組成物および方法
EP1706104A2 (en) * 2004-01-13 2006-10-04 Omega Bio-Pharma (I.P.2) Limited Methods for treating stress and affecting biological immune systems using a cysteamine compound
JP2005232148A (ja) * 2004-02-03 2005-09-02 Technion Research & Development Foundation Ltd 神経保護剤としてプロパルギルアミンの使用
JP4954864B2 (ja) 2004-04-01 2012-06-20 カーディオム ファーマ コーポレイション イオンチャネル調節化合物のプロドラッグおよびその使用
ITMI20040876A1 (it) * 2004-04-30 2004-07-30 Univ Degli Studi Milano Inibitori delle istone deacetilasi-hdac-quali agenti ipolipidemizzati per la terapia e la prevenzione dell'arteriosclerosi e malattie cardiovascolari
JP2008545663A (ja) * 2005-05-27 2008-12-18 クイーンズ ユニバーシティ アット キングストン タンパク質フォールディング障害の治療
FR2890563B1 (fr) * 2005-09-09 2007-10-19 Servier Lab Nouvelle association entre l'agomelatine et un agent thymoregulateur et les compositions pharmaceutiques qui la contiennent
US8263655B2 (en) * 2005-10-06 2012-09-11 Technion Research And Development Foundation Ltd Methods for treatment of renal failure
KR200453511Y1 (ko) * 2009-12-29 2011-05-13 한국강성(주) 마이크로 유에스비 커넥터 플러그
BR112012019374B1 (pt) 2010-02-03 2022-01-11 Pharma Two B Ltd Composição farmacêutica oral e uso de um agente ativo para a preparação de uma composição farmacêutica oral para o tratamento de doenças neurodegenerativas
WO2013120086A1 (en) * 2012-02-10 2013-08-15 Whitehead Institute For Biomedical Research Inhibition of the glycine cleavage system for treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218709D0 (en) * 1992-09-04 1992-10-21 Salim Aws S M Biologically active health formulation
EP1067922A1 (en) * 1998-03-30 2001-01-17 The Endowment For Research In Human Biology, Inc. Agents and methods for modulation of zinc transfer by metallothionein

Also Published As

Publication number Publication date
MXPA01010933A (es) 2002-06-21
CA2372073A1 (en) 2000-11-09
PL353180A1 (en) 2003-11-03
NO20015247L (no) 2001-10-26
US6395780B1 (en) 2002-05-28
EP1185259A1 (en) 2002-03-13
CZ20013786A3 (cs) 2002-02-13
AU4748100A (en) 2000-11-17
JP2002543124A (ja) 2002-12-17
BR0010151A (pt) 2002-06-11
KR20020008167A (ko) 2002-01-29
WO2000066110A1 (en) 2000-11-09

Similar Documents

Publication Publication Date Title
NO20015065D0 (no) Pyrazolobenzodiazepiner som CDK2-inhibitorer
DK1244647T3 (da) Quinzolinderivater som VIGF-inhibitorer
DK2253620T3 (da) Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer
NO20021239L (no) Pteridinoner som kinase-inhibitorer
NO20031006D0 (no) Imidazolo-5-yl-2-anilino-pyrimidiner som midler for inhibering av celleproliferasjon
EE200100492A (et) Ensüümi IMPDH inhibiitorid
PT1181017E (pt) Inibidores de metaloproteases
DK1526134T3 (da) Triazolyltropanderivater som CCR5-modulatorer
NO20015247D0 (no) Glysinspaltingssysteminhibitorer som potensielle antipsykotika
PT1194404E (pt) Inibidores de aspartil-protease
NO20014875L (no) Promedikamenter for trombin inhibitorer
NO20021959D0 (no) Tetrahydrotiopyranftalazinon-derivater som PDE4-inhibitorer
DK1144431T3 (da) 16-Hydroxyestratriener som selektivt aktive estrogener
DK1020430T3 (da) Middel indeholdende L-carnitin
NO20000094L (no) 6-Azaurcilderivater som IL-5 inhibitorer
NO20020592D0 (no) Fluorenderivater som integrininhibitorer
DK1181271T3 (da) Naphthalenurinstoffer som inhibitorer af glucoseoptagelse
SE9903511D0 (sv) Computer supported application
IT1311599B1 (it) Scopa particolarmente per esterni.
SE9902566D0 (sv) Tätningsring
DE29904969U1 (de) Haltesystem
CA85567S (fr) Bouteille
UA3199S (uk) Пляшка
UA3246S (uk) Пляшка
UA3113S (uk) Пляшка

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application